BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34061369)

  • 21. Impact of ypT, ypN, and Adjuvant Therapy on Survival in Gastric Cancer Patients Treated with Perioperative Chemotherapy and Radical Surgery.
    Coimbra FJF; de Jesus VHF; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Felismino T; Mello CAL; Almeida MF; Begnami MDFS; Dias-Neto E; Riechelmann RSP; da Costa WL
    Ann Surg Oncol; 2019 Oct; 26(11):3618-3626. PubMed ID: 31222685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant radiation therapy does not increase perioperative morbidity among patients undergoing gastrectomy for gastric cancer.
    Sun Z; Nussbaum DP; Speicher PJ; Czito BG; Tyler DS; Blazer DG
    J Surg Oncol; 2015 Jul; 112(1):46-50. PubMed ID: 26179329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor downstaging after neoadjuvant chemotherapy determines survival after surgery for gastric adenocarcinoma.
    Levenson G; Voron T; Paye F; Balladur P; Debove C; Chafai N; De Dios AG; Lefevre JH; Parc Y
    Surgery; 2021 Dec; 170(6):1711-1717. PubMed ID: 34561115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
    Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
    World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative preoperative characteristics and postoperative outcomes at a private versus a safety-net hospital following endoscopic endonasal transsphenoidal resection of pituitary adenomas.
    Cyprich J; Pangal DJ; Rutkowski M; Donoho DA; Shiroishi M; Jason Liu CS; Carmichael JD; Zada G
    J Neurosurg; 2020 Feb; 134(3):742-749. PubMed ID: 32109866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.
    Gakis G; Morgan TM; Daneshmand S; Keegan KA; Todenhöfer T; Mischinger J; Schubert T; Zaid HB; Hrbacek J; Ali-El-Dein B; Clayman RH; Galland S; Olugbade K; Rink M; Fritsche HM; Burger M; Chang SS; Babjuk M; Thalmann GN; Stenzl A; Efstathiou JA
    Ann Oncol; 2015 Aug; 26(8):1754-9. PubMed ID: 25969370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
    Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ
    Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR).
    Dos Santos M; Lequesne J; Leconte A; Corbinais S; Parzy A; Guilloit JM; Varatharajah S; Brachet PE; Dorbeau M; Vaur D; Weiswald LB; Poulain L; Le Gallic C; Castera-Tellier M; Galais MP; Clarisse B
    BMC Cancer; 2022 May; 22(1):537. PubMed ID: 35549674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current status and prospect of perioperative therapy for locally advanced gastric cancer].
    Zhu ZG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):101-106. PubMed ID: 33508913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors and Prognostic Implications of Perioperative Chemotherapy Completion in Gastric Cancer.
    Karagkounis G; Squires MH; Melis M; Poultsides GA; Worhunsky D; Jin LX; Fields RC; Spolverato G; Pawlik TM; Votanopoulos KI; Levine EA; Schmidt C; Bloomston M; Cho CS; Weber S; Masi A; Berman R; Pachter HL; Staley CA; Newman E; Maithel SK; Hatzaras I
    J Gastrointest Surg; 2017 Dec; 21(12):1984-1992. PubMed ID: 28963709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidisciplinary Teams Improve Gastric Cancer Treatment Efficiency at a Large Safety Net Hospital.
    Ju M; Wang SC; Syed S; Agrawal D; Porembka MR
    Ann Surg Oncol; 2020 Mar; 27(3):645-650. PubMed ID: 31677108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National Trends and Clinical Outcomes of Type B Aortic Dissection Management at Safety-Net Hospitals.
    Cho NY; Chervu N; Verma A; Ebrahimian S; Kim S; Rollo J; Benharash P
    Am Surg; 2023 Oct; 89(10):4105-4110. PubMed ID: 37212236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radical Gastrectomy: Still the Cornerstone of Curative Treatment for Gastric Cancer in the Perioperative Chemotherapy Era-A Single Institute Experience over a Decade.
    Kanhere H; Goel R; Finlay B; Trochsler M; Maddern G
    Int J Surg Oncol; 2018; 2018():9371492. PubMed ID: 29568650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
    Barone C; Cassano A; Pozzo C; D'Ugo D; Schinzari G; Persiani R; Basso M; Brunetti IM; Longo R; Picciocchi A
    Oncology; 2004; 67(1):48-53. PubMed ID: 15459495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term outcomes of gastrectomy after neoadjuvant chemotherapy for clinical stage III gastric cancer: propensity score-matched analysis of a multi-institutional database.
    Umeda S; Kanda M; Nakanishi K; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Shimizu D; Kobayashi D; Tanaka C; Fujiwara M; Murotani K; Kodera Y
    Surg Today; 2021 May; 51(5):821-828. PubMed ID: 33170366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Exploration and thoughts on perioperative treatment of advanced gastric cancer].
    Li YF; Zhou ZW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):112-117. PubMed ID: 33508915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FLOT Neoadjuvant Chemotherapy Followed by Laparoscopic D2 Gastrectomy in the Treatment of Locally Resectable Advanced Gastric Cancer.
    Zhang S; Yan D; Sun Q; Du T; Cao D; Yang Y; Yuan B; Li H; Jiang X; Song C
    Can J Gastroenterol Hepatol; 2020; 2020():1702823. PubMed ID: 32566545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy and safety of neoadjuvant chemotherapy on patients with advanced gastric cancer: A multicenter randomized clinical trial.
    Zhao Q; Lian C; Huo Z; Li M; Liu Y; Fan L; Tan B; Zhao X; Zhang Z; Wang D; Liu Y; Guo H; Yang P; Tian Y; Li Y
    Cancer Med; 2020 Aug; 9(16):5731-5745. PubMed ID: 32583567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative analysis on clinical efficacy of FOLFOX6 regimen and DCF regimen as neoadjuvant chemotherapy combined with radical gastrectomy in treating advanced gastric cancer.
    Tai Q; Shao H; Liu Y; Li E; Zhao R
    J BUON; 2019; 24(5):2006-2012. PubMed ID: 31786868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissecting disease, race, ethnicity, and socioeconomic factors for hepatocellular carcinoma: An analysis from the United States Safety Net Collaborative.
    Lee RM; Gamboa AC; Turgeon MK; Yopp A; Ryon EL; Kronenfeld JP; Goel N; Wang A; Lee AY; Luu S; Hsu C; Silberfein E; Maithel SK; Russell MC
    Surg Oncol; 2020 Dec; 35():120-125. PubMed ID: 32871546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.